New features such as multilingual audio guidance, simplified instructions and a more accessible interface enable healthcare providers to reach a broader patient base.
Toronto, Canada, Nov. 5, 2024 (GLOBE NEWSWIRE) — Creyos, a leader in cognitive and behavioral health assessment, has announced significant enhancements to its online platform to improve accessibility and ease of use for patients. These updates are part of Creyos’ ongoing commitment to ensuring that all patients, regardless of background or abilities, have the opportunity to successfully complete cognitive and behavioral health assessments, providing healthcare providers with accurate, actionable and reliable data.
The updates address the increasing demand for more inclusive cognitive and behavioral healthcare, as well as the impact of social determinants of health on healthcare delivery. Older adults from historically underserved communities are 18% less likely to receive a timely diagnosis of Alzheimer’s disease and related dementias, compared to people in areas of higher socioeconomic status. Several studies have pointed out the inappropriateness of traditional cognitive tests such as the Mini-Cog and Mini-Cog. Mental State Examination (MMSE) for low-literate population groups. These communities also often face challenges such as limited familiarity with technology and reduced access to care, making easy-to-use and accessible health assessments critical. Creyos’ enhanced platform addresses these issues with an improved user interface, simplified instructions, multilingual voiceover guidance, and built-in tutorials designed to meet the needs of diverse patient populations.
“Improving equity in healthcare means ensuring that every patient, regardless of background, has a clear understanding of the cognitive assessments they undertake,” says Professor Adrian Owen, OBE, FRS, PhD, neuroscientist and Chief Scientific Officer at Creyos. “This is especially crucial in circumstances where early and accurate detection can make a difference, such as dementia. When patients fully understand what is expected of them, we achieve more accurate and reliable results, which are essential for effective diagnosis and treatment. It’s not just about providing access; it’s about equipping healthcare providers with the right tools to drive better clinical decision making and patient outcomes.”
For healthcare providers, the updated patient experience streamlines the process of interacting with patients, removing barriers that previously prevented individuals from conducting critical assessments. The improvements make it easier for healthcare systems and clinics to address disparities in brain health through the following updates:
Simplified introduction: Creyos’ updated patient experience provides introductory instructions at an accessible reading level suitable for low-literacy patients, allowing them to navigate the assessments with confidence.
Tutorials optimized for learning: Tutorials include visual, audio, and tactile guidance to support all learning styles and engage patients, ensuring a seamless experience for diverse populations.
Improved task accessibility: Creyos has upgraded its task design to be more accessible, without changing the core mechanics to maintain scientific validity. Improvements include contrast adjustments for color-blind users, multilingual voiceovers, larger text size, a more visually comfortable interface for users with brain injuries, and reduced on-screen distractions. These changes ensure that the Creyos patient experience meets WCAG requirements while maintaining the integrity of the resulting data.
New questionnaires: Creyos has redesigned its questionnaires to be clearer, faster and more accurate. The questionnaire display has been simplified to reduce distractions and now features scrollable formats with contextual information available via pop-out modalities for added clarity.
“Cognitive health problems are often dangerously underdiagnosed, with significant consequences for patients, their caregivers and society as a whole,” said Marc Lipton, President and Chief Executive Officer at Creyos. “The updates we have made to the patient experience are designed to ensure that no one needing screening, diagnostic support, assessment or ongoing monitoring slips through the cracks. This is not just about helping individual patients; it’s about expanding our collective understanding of cognitive disorders. More accurate, objective data leads to better-informed physician interventions, both now and in the future.”
This release is part of Creyos’ strategic focus on supporting healthcare systems and providers caring for high-risk patient populations, including populations considered to have a higher prevalence of cognitive decline and mental health conditions. Through these improvements, Creyos helps physicians address gaps in care and deliver timely, evidence-based interventions. The updated patient experience will be available soon for all Creyos accounts.
About Creyos
Creyos, formerly known as Cambridge Brain Sciences, is a pioneering healthcare technology company committed to transforming the way physicians assess and manage patients’ brain health. The Creyos platform supports healthcare providers around the world, offering objective online tasks, digitized behavioral health screeners and condition-focused protocols to provide actionable insights, support early intervention and deliver evidence-based solutions for a wide range of cognitive and behavioral health issues. Backed by 30 years of research and a normative database of more than 85,000 participants, Creyos has been used in more than 400 peer-reviewed studies and is recognized as a scientifically validated solution for measuring and monitoring patient cognition and behavioral health. For more information about Creyos, please visit www.creyos.com.
by 
